Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2013

Open Access 01-12-2013 | Research article

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data

Authors: Jaana Kaunisto, Eija-Riitta Salomaa, Ulla Hodgson, Riitta Kaarteenaho, Marjukka Myllärniemi

Published in: BMC Pulmonary Medicine | Issue 1/2013

Login to get access

Abstract

Background

Recent studies suggest that the incidence of idiopathic pulmonary fibrosis (IPF) is rising. Accurate epidemiological data on IPF, however, are sparse and the results of previous studies are contradictory. This study was undertaken to gain insight into the various methods used in the epidemiological research of IPF, and to get accurate and comparable data on these different methodologies.

Methods

A systematic database search was performed in order to identify all epidemiological studies on IPF after the previous guidelines for diagnosis and treatment were published in 2000. Medline (via Pubmed), Science Sitation Index (via Web of Science) and Embase databases were searched for original epidemiological articles published in English in international peer-reviewed journals starting from 2001. After pre-screening and a full-text review, 13 articles were accepted for data abstraction.

Results

Three different methodologies of epidemiological studies were most commonly used, namely: 1) national registry databases, 2) questionnaire-based studies, and 3) analysis of the health care system’s own registry databases. The overall prevalence and incidence of IPF varied in these studies between 0.5–27.9/100,000 and 0.22–8.8/100,000, respectively. According to four studies the mortality and incidence of IPF are rising.

Conclusions

We conclude that there are numerous ways to execute epidemiological research in the field of IPF. This review offers the possibility to compare the different methodologies that have been used, and this information could form a basis for future studies investigating the prevalence and incidence of IPF.
Appendix
Available only for authorised users
Literature
1.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183: 788-824. 10.1164/rccm.2009-040GL.CrossRefPubMed Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183: 788-824. 10.1164/rccm.2009-040GL.CrossRefPubMed
2.
go back to reference Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM, CAPACITY Study Group: Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011, 377: 1760-1769. 10.1016/S0140-6736(11)60405-4.CrossRefPubMed Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM, CAPACITY Study Group: Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011, 377: 1760-1769. 10.1016/S0140-6736(11)60405-4.CrossRefPubMed
3.
go back to reference Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, Nukiwa T, Pirfenidone Clinical Study Group in Japan: Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010, 35: 821-829. 10.1183/09031936.00005209.CrossRefPubMed Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, Nukiwa T, Pirfenidone Clinical Study Group in Japan: Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010, 35: 821-829. 10.1183/09031936.00005209.CrossRefPubMed
4.
go back to reference Izumi S, Iikura M, Hirano S: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012, 30: 367-870. Izumi S, Iikura M, Hirano S: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012, 30: 367-870.
5.
go back to reference American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000, 161: 646-664.CrossRef American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000, 161: 646-664.CrossRef
6.
go back to reference American Thoracic Society: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002, 165: 277-304.CrossRef American Thoracic Society: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002, 165: 277-304.CrossRef
7.
go back to reference Guenther A: The European IPF Network: towards better care for a dreadful disease. Eur Respir J. 2011, 37: 747-748. 10.1183/09031936.00012111.CrossRefPubMed Guenther A: The European IPF Network: towards better care for a dreadful disease. Eur Respir J. 2011, 37: 747-748. 10.1183/09031936.00012111.CrossRefPubMed
8.
go back to reference Macansch S, Glaspole I, Hopkins P, Moodley Y, Reynolds P, Walters H, Zappala C, Chapman S, Cooper W, Darbishire W, Ellis S, Corte TJ: The Australian Idiopathic Pulmonary Fibrosis Registry – A National Collaboration Provides Epidemiological Insights And Research Opportunities. Am J Respir Crit Care Med. 2013, 187: A1457- Macansch S, Glaspole I, Hopkins P, Moodley Y, Reynolds P, Walters H, Zappala C, Chapman S, Cooper W, Darbishire W, Ellis S, Corte TJ: The Australian Idiopathic Pulmonary Fibrosis Registry – A National Collaboration Provides Epidemiological Insights And Research Opportunities. Am J Respir Crit Care Med. 2013, 187: A1457-
9.
go back to reference Thomeer MJ, Costabel U, Rizzato G, Poletti V, Demedts M: Comparison of registries on interstitial lung diseases in three European countries. Eur Respir J. 2001, 18: 114s-118s. Thomeer MJ, Costabel U, Rizzato G, Poletti V, Demedts M: Comparison of registries on interstitial lung diseases in three European countries. Eur Respir J. 2001, 18: 114s-118s.
10.
go back to reference Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK: Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death. Respir Med. 2012, 106: 588-593. 10.1016/j.rmed.2012.01.002.CrossRefPubMedPubMedCentral Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK: Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death. Respir Med. 2012, 106: 588-593. 10.1016/j.rmed.2012.01.002.CrossRefPubMedPubMedCentral
11.
go back to reference Lederer DJ, Arcasoy SM, Barr RG, Wilt J, Bagiella E, D’Ovidio F, Sonett JR, Kawutt SM: Racial and ethnic disparities in idiopathic pulmonary fibrosis: a UNOS/OPTN database analysis. Am J Transplant. 2006, 6: 2436-2442. 10.1111/j.1600-6143.2006.01480.x.CrossRefPubMedPubMedCentral Lederer DJ, Arcasoy SM, Barr RG, Wilt J, Bagiella E, D’Ovidio F, Sonett JR, Kawutt SM: Racial and ethnic disparities in idiopathic pulmonary fibrosis: a UNOS/OPTN database analysis. Am J Transplant. 2006, 6: 2436-2442. 10.1111/j.1600-6143.2006.01480.x.CrossRefPubMedPubMedCentral
12.
go back to reference Jeon K, Chung MP, Lee KS, Chung MJ, Han J, Koh W-J, Suh GY, Kim H, Kwon OJ: Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis. Respir Med. 2006, 100: 451-457. 10.1016/j.rmed.2005.06.013.CrossRefPubMed Jeon K, Chung MP, Lee KS, Chung MJ, Han J, Koh W-J, Suh GY, Kim H, Kwon OJ: Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis. Respir Med. 2006, 100: 451-457. 10.1016/j.rmed.2005.06.013.CrossRefPubMed
13.
go back to reference Miyake Y, Sasaki S, Yokoyama T, Chida K, Azuma A, Suda T, Kudoh S, Sakamoto N, Okamoto K, Kobashi G, Washio M, Inaba Y, Tanaka H: Case–control study of medical history and idiopathic pulmonary fibrosis in Japan. Respirology. 2005, 10: 504-509. 10.1111/j.1440-1843.2005.00742.x.CrossRefPubMed Miyake Y, Sasaki S, Yokoyama T, Chida K, Azuma A, Suda T, Kudoh S, Sakamoto N, Okamoto K, Kobashi G, Washio M, Inaba Y, Tanaka H: Case–control study of medical history and idiopathic pulmonary fibrosis in Japan. Respirology. 2005, 10: 504-509. 10.1111/j.1440-1843.2005.00742.x.CrossRefPubMed
14.
go back to reference Young LM, Hopkins R, Wilsher ML: Lower occurrence of idiopathic pulmonary fibrosis in Maori and Pacific Islanders. Respirology. 2006, 11: 467-470. 10.1111/j.1440-1843.2006.00872.x.CrossRefPubMed Young LM, Hopkins R, Wilsher ML: Lower occurrence of idiopathic pulmonary fibrosis in Maori and Pacific Islanders. Respirology. 2006, 11: 467-470. 10.1111/j.1440-1843.2006.00872.x.CrossRefPubMed
15.
go back to reference Olson AL, Swigris JJ, Raghu G, Brown KK: Seasonal Variotion. Mortality From Pulmonary Fibrosis Is Greatest in the Winter. Chest. 2009, 136: 16-22. 10.1378/chest.08-0703.CrossRefPubMed Olson AL, Swigris JJ, Raghu G, Brown KK: Seasonal Variotion. Mortality From Pulmonary Fibrosis Is Greatest in the Winter. Chest. 2009, 136: 16-22. 10.1378/chest.08-0703.CrossRefPubMed
16.
go back to reference Agostini C, Albera C, Bariffi F, De Palma M, Harari S, Lusuardi M, Pesci A, Poletti V, Richledi L, Riazzato G, Rossi A, Schiavina M, Semenzato G, Tinelli C: First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis. 2001, 56: 364-368.PubMed Agostini C, Albera C, Bariffi F, De Palma M, Harari S, Lusuardi M, Pesci A, Poletti V, Richledi L, Riazzato G, Rossi A, Schiavina M, Semenzato G, Tinelli C: First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis. 2001, 56: 364-368.PubMed
17.
go back to reference Sen T, Udwadia ZF: Retrospective Study of Interstitial Lung Disease in a Tertiary Care Centre in India. Indian J Chest Dis Allied Sci. 2010, 52: 207-211.PubMed Sen T, Udwadia ZF: Retrospective Study of Interstitial Lung Disease in a Tertiary Care Centre in India. Indian J Chest Dis Allied Sci. 2010, 52: 207-211.PubMed
18.
go back to reference Thomeer M, Demedts M, Vandeurzen K: Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001, 56: 163-172.CrossRefPubMed Thomeer M, Demedts M, Vandeurzen K: Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001, 56: 163-172.CrossRefPubMed
19.
go back to reference Tinelli C, De Silvestri A, Richeldi L, Tiberio O: The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasc Diffuse Lung Dis. 2005, 22: S4-S8.PubMed Tinelli C, De Silvestri A, Richeldi L, Tiberio O: The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasc Diffuse Lung Dis. 2005, 22: S4-S8.PubMed
20.
go back to reference Xaubet A, Ancochea J, Morell F, Spanish Group on Interstitial Lung Diseases, SEPAR, et al: Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004, 21: 64-70.PubMed Xaubet A, Ancochea J, Morell F, Spanish Group on Interstitial Lung Diseases, SEPAR, et al: Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004, 21: 64-70.PubMed
21.
go back to reference Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, Latsi P, Polychronopoulos V, Birba G, Ch L, Bouros D: Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009, 103: 1122-1229. 10.1016/j.rmed.2009.03.001.CrossRefPubMed Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, Latsi P, Polychronopoulos V, Birba G, Ch L, Bouros D: Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009, 103: 1122-1229. 10.1016/j.rmed.2009.03.001.CrossRefPubMed
22.
go back to reference Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002, 57: 338-342. 10.1136/thorax.57.4.338.CrossRefPubMedPubMedCentral Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002, 57: 338-342. 10.1136/thorax.57.4.338.CrossRefPubMedPubMedCentral
23.
go back to reference Von Plessen C, Grinde Ø, Gulsvik A: Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respir Med. 2003, 97: 428-435. 10.1053/rmed.2002.1466.CrossRefPubMed Von Plessen C, Grinde Ø, Gulsvik A: Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respir Med. 2003, 97: 428-435. 10.1053/rmed.2002.1466.CrossRefPubMed
24.
go back to reference Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ: Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006, 61: 980-985. 10.1136/thx.2006.062836.CrossRefPubMedPubMedCentral Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ: Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006, 61: 980-985. 10.1136/thx.2006.062836.CrossRefPubMedPubMedCentral
25.
go back to reference Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G: Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006, 174: 810-816. 10.1164/rccm.200602-163OC.CrossRefPubMed Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G: Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006, 174: 810-816. 10.1164/rccm.200602-163OC.CrossRefPubMed
26.
go back to reference Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson G, Brown KK: Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007, 176: 277-284. 10.1164/rccm.200701-044OC.CrossRefPubMed Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson G, Brown KK: Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007, 176: 277-284. 10.1164/rccm.200701-044OC.CrossRefPubMed
27.
go back to reference Ohno S, Nakaya T, Bando M, Sugiyma Y: Idiopathic pulmonary fibrosis – results from a Japanese nationwide epidemiological survey using individual clinical records. Respirology. 2008, 13: 926-928. 10.1111/j.1440-1843.2008.01349.x.CrossRefPubMed Ohno S, Nakaya T, Bando M, Sugiyma Y: Idiopathic pulmonary fibrosis – results from a Japanese nationwide epidemiological survey using individual clinical records. Respirology. 2008, 13: 926-928. 10.1111/j.1440-1843.2008.01349.x.CrossRefPubMed
28.
go back to reference Fernández Pérez ER, Daniels CE, Schroede DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES, Ruy JH: Incidence, Prevalence and Clinical Course of Idiopathic Pulmonary Fibrosis. Chest. 2010, 137: 129-137. 10.1378/chest.09-1002.CrossRefPubMed Fernández Pérez ER, Daniels CE, Schroede DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES, Ruy JH: Incidence, Prevalence and Clinical Course of Idiopathic Pulmonary Fibrosis. Chest. 2010, 137: 129-137. 10.1378/chest.09-1002.CrossRefPubMed
29.
go back to reference Navaratnam V, Fleming KM, West J, Smith CJP, Jenkins RG, Fogarty A, Hubbard RB: The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax. 2011, 66: 462-467. 10.1136/thx.2010.148031.CrossRefPubMed Navaratnam V, Fleming KM, West J, Smith CJP, Jenkins RG, Fogarty A, Hubbard RB: The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax. 2011, 66: 462-467. 10.1136/thx.2010.148031.CrossRefPubMed
30.
go back to reference Lai CC, Wang C-Y, Lu H-M, Chen L, Teng N-C, Yan Y-H, Wang J-Y, Chang Y-T, Chao T-T, Lin H-I, Chen C-R, Yu C-J, Wang J-D: Idiopathic pulmonary fibrosis in Taiwan – A population-based study. Respir Med. 2012, 106: 1566-1574. 10.1016/j.rmed.2012.07.012.CrossRefPubMed Lai CC, Wang C-Y, Lu H-M, Chen L, Teng N-C, Yan Y-H, Wang J-Y, Chang Y-T, Chao T-T, Lin H-I, Chen C-R, Yu C-J, Wang J-D: Idiopathic pulmonary fibrosis in Taiwan – A population-based study. Respir Med. 2012, 106: 1566-1574. 10.1016/j.rmed.2012.07.012.CrossRefPubMed
31.
go back to reference Liebow A: Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res. 1975, 8: 1-31.CrossRef Liebow A: Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res. 1975, 8: 1-31.CrossRef
32.
go back to reference Coultas DB, Zumwalt RE, Black WC, Sobonya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994, 150: 967-972. 10.1164/ajrccm.150.4.7921471.CrossRefPubMed Coultas DB, Zumwalt RE, Black WC, Sobonya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994, 150: 967-972. 10.1164/ajrccm.150.4.7921471.CrossRefPubMed
33.
go back to reference Turner-Warwick M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980, 35: 171-180. 10.1136/thx.35.3.171.CrossRefPubMedPubMedCentral Turner-Warwick M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980, 35: 171-180. 10.1136/thx.35.3.171.CrossRefPubMedPubMedCentral
34.
go back to reference Behr J, Hoeper MM, Kreuter M, Klotsche J, Wirtz H, Pittrow D: Characteristics and management of idiopathic pulmonary fibrosis: INSIGHT-IPF registry. Dtsch Med Wochenschr. 2012, 137: 2586-2588.CrossRefPubMed Behr J, Hoeper MM, Kreuter M, Klotsche J, Wirtz H, Pittrow D: Characteristics and management of idiopathic pulmonary fibrosis: INSIGHT-IPF registry. Dtsch Med Wochenschr. 2012, 137: 2586-2588.CrossRefPubMed
35.
go back to reference Liebow AA, Carrington CB: The interstitial pneumonias. Frontiers in pulmonary radiology. Edited by: Simon M, Potchen EJ, Lemay E. 1969, New York: Grune and Stratton, 102-141. Liebow AA, Carrington CB: The interstitial pneumonias. Frontiers in pulmonary radiology. Edited by: Simon M, Potchen EJ, Lemay E. 1969, New York: Grune and Stratton, 102-141.
36.
go back to reference Katzenstein AL, Fiorelli RF: Nonspesific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994, 18: 136-147. 10.1097/00000478-199402000-00003.CrossRefPubMed Katzenstein AL, Fiorelli RF: Nonspesific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994, 18: 136-147. 10.1097/00000478-199402000-00003.CrossRefPubMed
37.
go back to reference Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998, 157: 1301-1315. 10.1164/ajrccm.157.4.9707039.CrossRefPubMed Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998, 157: 1301-1315. 10.1164/ajrccm.157.4.9707039.CrossRefPubMed
38.
go back to reference Larsen BT, Colby TV: Update for pathologists on idiopathic interstitial pneumonias. Arch Pathol Lab Med. 2012, 136: 1234-1241. 10.5858/arpa.2012-0225-RA.CrossRefPubMed Larsen BT, Colby TV: Update for pathologists on idiopathic interstitial pneumonias. Arch Pathol Lab Med. 2012, 136: 1234-1241. 10.5858/arpa.2012-0225-RA.CrossRefPubMed
39.
go back to reference Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR: Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2012, (published online before print) Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR: Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2012, (published online before print)
40.
go back to reference Macansh S, Glaspole I, Goh N, Hopkins P, Moodley Y, Reynolds P, Walters H, Wood-Baker R, Zappala C, Chapman S, Cooper W, Darbishire W, Ellis S, Mahar A, Chaplin H, Fuller J, Mcalister M, Stevens E, Symons K, Webster S, Corte TJ: The australian idiopathic pulmonary fibrosis registry: a national collaboration. Respirology. 2013, 18: 72- Macansh S, Glaspole I, Goh N, Hopkins P, Moodley Y, Reynolds P, Walters H, Wood-Baker R, Zappala C, Chapman S, Cooper W, Darbishire W, Ellis S, Mahar A, Chaplin H, Fuller J, Mcalister M, Stevens E, Symons K, Webster S, Corte TJ: The australian idiopathic pulmonary fibrosis registry: a national collaboration. Respirology. 2013, 18: 72-
41.
go back to reference Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D: Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 2012, 21: 355-361. 10.1183/09059180.00002512.CrossRefPubMed Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D: Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 2012, 21: 355-361. 10.1183/09059180.00002512.CrossRefPubMed
Metadata
Title
Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
Authors
Jaana Kaunisto
Eija-Riitta Salomaa
Ulla Hodgson
Riitta Kaarteenaho
Marjukka Myllärniemi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2013
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-13-53

Other articles of this Issue 1/2013

BMC Pulmonary Medicine 1/2013 Go to the issue